Postprandial lipemia as a cardiometabolic risk factor

References

• McBride PE. Triglycerides and risk for coronary heart disease. JAMA 2007;298:336-8
   PubMed Web of Science ®Google Scholar
• Kannel WB, Vasan RS. Triglycerides as vascular risk factors: new epidemiologic insights. Curr Opin Cardiol 2009;24:345-50
   PubMed Web of Science ®Google Scholar
• Goldberg IJ, Eckel RH, McPherson R. Triglycerides and heart disease: still a hypothesis? Arterioscler Thromb Vasc Biol 2011;31:1716-25
   PubMed Web of Science ®Google Scholar
• Chapman MJ, Ginsberg HN, Amarenco P, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 2011;32:1345-61
   PubMed Web of Science ®Google Scholar
• Varbo A, Benn M, Tybjaerg-Hansen A, et al. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol 2013;61:427-36
   PubMed Web of Science ®Google Scholar
• Do R, Willer CJ, Schmidt EM, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet 2013;45:1345-52
   PubMed Web of Science ®Google Scholar
• Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979;60:473-85
   PubMed Web of Science ®Google Scholar
• Sniderman AD. Postprandial hypertriglyceridemia(s): time to enlarge our pathophysiologic perspective. Eur J Clin Invest 2000;30:935-7
   PubMed Web of Science ®Google Scholar
• Patsch JR, Miesenbock G, Hopferwieser T, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992;12:1336-45
   PubMed Web of Science ®Google Scholar
• Proctor SD, Vine DF, Mamo JC. Arterial retention of apolipoprotein B(48)- and B(100)-containing lipoproteins in atherogenesis. Curr Opin Lipidol 2002;13:461-70
   PubMed Web of Science ®Google Scholar
• Patel S, Puranik R, Nakhla S, et al. Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. Atherosclerosis 2009;204:424-8
   PubMed Web of Science ®Google Scholar
• Norata GD, Pirillo A, Ammirati E, et al. Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis 2012;220:11-21
   PubMed Web of Science ®Google Scholar
• Nakajima K, Nakano T, Tokita Y, et al. Postprandial lipoprotein metabolism: VLDL vs chylomicrons. Clin Chim Acta 2011;412:1306-18
   PubMed Web of Science ®Google Scholar
• Pirillo A, Norata GD, Catapano AL. Production and Metabolism of Triglyceride-Rich Lipoproteins in Both the Normal and Diabetic States. New York: Humana Press, 2014
   Google Scholar
• Twickler T, Dallinga-Thie GM, Chapman MJ, et al. Remnant lipoproteins and atherosclerosis. Curr Atheroscler Rep 2005;7:140-7
   PubMedGoogle Scholar
• Fujioka Y, Ishikawa Y. Remnant lipoproteins as strong key particles to atherogenesis. J Atheroscler Thromb 2009;16:145-54
   PubMed Web of Science ®Google Scholar
• Karpe F, Bell M, Bjorkegren J, et al. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100. Arterioscler Thromb Vasc Biol 1995;15:199-207
   PubMed Web of Science ®Google Scholar
• Schneeman BO, Kotite L, Todd KM, et al. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci USA 1993;90:2069-73
   PubMed Web of Science ®Google Scholar
• Adiels M, Matikainen N, Westerbacka J, et al. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity. Atherosclerosis 2012;222:222-8
   PubMed Web of Science ®Google Scholar
• Cohn JS. Postprandial lipemia and remnant lipoproteins. Clin Lab Med 2006;26:773-86
   PubMed Web of Science ®Google Scholar
• Ooi EM, Barrett PH, Chan DC, et al. Apolipoprotein C-III: understanding an emerging cardiovascular risk factor. Clin Sci (Lond) 2008;114:611-24
   PubMed Web of Science ®Google Scholar
• Hsieh J, Hayashi AA, Webb J, et al. Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity. Atheroscler Suppl 2008;9:7-13
   PubMed Web of Science ®Google Scholar
• Pastromas S, Terzi AB, Tousoulis D, et al. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus. Int J Cardiol 2008;126:3-12
   PubMed Web of Science ®Google Scholar
• Chan DC, Watts GF. Postprandial lipoprotein metabolism in familial hypercholesterolemia: thinking outside the box. Metabolism 2012;61:3-11
   PubMed Web of Science ®Google Scholar
• Pavlidis AN, Kolovou GD, Anagnostopoulou KK, et al. Postprandial metabolic heterogeneity in men with primary dyslipidaemia. Arch Med Sci 2010;6:879-86
   PubMed Web of Science ®Google Scholar
• Twickler TB, Dallinga-Thie GM, Cohn JS, et al. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype. Circulation 2004;109:1918-25
   PubMed Web of Science ®Google Scholar
• Cohn JS, McNamara JR, Cohn SD, et al. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 1988;29:469-79
   PubMed Web of Science ®Google Scholar
• Puga GM, Meyer C, Everman S, et al. Postprandial lipemia in the elderly involves increased incorporation of ingested fat in plasma free fatty acids and small (Sf 20-400) triglyceride-rich lipoproteins. Am J Physiol Endocrinol Metab 2011;301:E356-61
   PubMed Web of Science ®Google Scholar
• Lobstein T, Baur L, Uauy R. Obesity in children and young people: a crisis in public health. Obes Rev 2004;5(Suppl 1):4-104
   PubMedGoogle Scholar
• Su JW, Ugo Nzekwu MM, Ball GD, et al. Postprandial lipemia as an early predictor of cardiovascular complications in childhood obesity. J Clin Lipidol 2009;3:78-84
   PubMed Web of Science ®Google Scholar
• Couillard C, Bergeron N, Prud'homme D, et al. Gender difference in postprandial lipemia: importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol 1999;19:2448-55
   PubMed Web of Science ®Google Scholar
• van Beek AP, de Ruijter-Heijstek FC, Erkelens DW, et al. Menopause is associated with reduced protection from postprandial lipemia. Arterioscler Thromb Vasc Biol 1999;19:2737-41
   PubMed Web of Science ®Google Scholar
• Westerveld HE. Estrogens and postprandial lipid metabolism. Atherosclerosis 1998;141(Suppl 1):S105-7
   PubMed Web of Science ®Google Scholar
• Pirro M, Lupattelli G, Siepi D, et al. Postprandial lipemia and associated metabolic disturbances in healthy and hyperlipemic postmenopausal women. Metabolism 2001;50:330-4
   PubMed Web of Science ®Google Scholar
• Kolovou GD, Anagnostopoulou KK, Pilatis ND, et al. The influence of natural menopause on postprandial lipemia in heterozygotes for familial hypercholesterolemia. J Womens Health (Larchmt) 2004;13:1119-26
   PubMed Web of Science ®Google Scholar
• Weintraub M, Grosskopf I, Charach G, et al. Hormone replacement therapy enhances postprandial lipid metabolism in postmenopausal women. Metabolism 1999;48:1193-6
   PubMed Web of Science ®Google Scholar
• Masding MG, Stears AJ, Burdge GC, et al. The benefits of oestrogens on postprandial lipid metabolism are lost in post-menopausal women with Type 2 diabetes. Diabet Med 2006;23:768-74
   PubMed Web of Science ®Google Scholar
• Lopez-Miranda J, Williams C, Lairon D. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 2007;98:458-73
   PubMed Web of Science ®Google Scholar
• Heden TD, Liu Y, Sims LJ, et al. Meal frequency differentially alters postprandial triacylglycerol and insulin concentrations in obese women. Obesity (Silver Spring) 2013;21:123-9
   PubMed Web of Science ®Google Scholar
• Murphy MC, Chapman C, Lovegrove JA, et al. Meal frequency; does it determine postprandial lipaemia? Eur J Clin Nutr 1996;50:491-7
   PubMed Web of Science ®Google Scholar
• Peddie MC, Rehrer NJ, Perry TL. Physical activity and postprandial lipidemia: are energy expenditure and lipoprotein lipase activity the real modulators of the positive effect? Prog Lipid Res 2012;51:11-22
   PubMed Web of Science ®Google Scholar
• Hurren NM, Eves FF, Blannin AK. Is the effect of prior exercise on postprandial lipaemia the same for a moderate-fat meal as it is for a high-fat meal? Br J Nutr 2011;105:506-16
   PubMed Web of Science ®Google Scholar
• Athyros VG, Katsiki N, Doumas M, et al. Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. Curr Med Res Opin 2013;29:1263-74
   PubMed Web of Science ®Google Scholar
• Mero N, Syvanne M, Eliasson B, et al. Postprandial elevation of ApoB-48-containing triglyceride-rich particles and retinyl esters in normolipemic males who smoke. Arterioscler Thromb Vasc Biol 1997;17:2096-102
   PubMed Web of Science ®Google Scholar
• van Tol A, van der Gaag MS, Scheek LM, et al. Changes in postprandial lipoproteins of low and high density caused by moderate alcohol consumption with dinner. Atherosclerosis 1998;141(Suppl 1):S101-3
   PubMed Web of Science ®Google Scholar
• Suter PM, Gerritsen-Zehnder M, Hasler E, et al. Effect of alcohol on postprandial lipemia with and without preprandial exercise. J Am Coll Nutr 2001;20:58-64
   PubMed Web of Science ®Google Scholar
• Mudrakova E, Poledne R, Kovar J. Postprandial triglyceridemia after single dose of alcohol in healthy young men. Nutr Metab Cardiovasc Dis 2013;23:183-8
   PubMed Web of Science ®Google Scholar
• Pownall HJ, Ballantyne CM, Kimball KT, et al. Effect of moderate alcohol consumption on hypertriglyceridemia: a study in the fasting state. Arch Intern Med 1999;159:981-7
   PubMed Web of Science ®Google Scholar
• Schneider J, Tesdorfpf M, Kaffarnik H, et al. Alteration of plasma lipids and intermediates of lipid metabolism in healthy fasting volunteers by ethanol and fructose. Res Exp Med (Berl) 1976;167:159-70
   PubMedGoogle Scholar
• Fielding BA, Reid G, Grady M, et al. Ethanol with a mixed meal increases postprandial triacylglycerol but decreases postprandial non-esterified fatty acid concentrations. Br J Nutr 2000;83:597-604
   PubMed Web of Science ®Google Scholar
• Duez H, Lamarche B, Uffelman KD, et al. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler Thromb Vasc Biol 2006;26:1357-63
   PubMed Web of Science ®Google Scholar
• Vansant G, Mertens A, Muls E. Determinants of postprandial lipemia in obese women. Int J Obes Relat Metab Disord 1999;23(Suppl 1):14-21
   PubMed Web of Science ®Google Scholar
• Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-77
   PubMed Web of Science ®Google Scholar
• Guerci B, Verges B, Durlach V, et al. Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patients. Int J Obes Relat Metab Disord 2000;24:468-78
   PubMed Web of Science ®Google Scholar
• Lewis GF, O'Meara NM, Soltys PA, et al. Postprandial lipoprotein metabolism in normal and obese subjects: comparison after the vitamin A fat-loading test. J Clin Endocrinol Metab 1990;71:1041-50
   PubMed Web of Science ®Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421
   Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28
   PubMed Web of Science ®Google Scholar
• Sarti C, Gallagher J. The metabolic syndrome: prevalence, CHD risk, and treatment. J Diabetes Complications 2006;20:121-32
   PubMed Web of Science ®Google Scholar
• Perez-Caballero AI, Alcala-Diaz JF, Perez-Martinez P, et al. Lipid metabolism after an oral fat test meal is affected by age-associated features of metabolic syndrome, but not by age. Atherosclerosis 2013;226:258-62
   PubMed Web of Science ®Google Scholar
• Jackson KG, Walden CM, Murray P, et al. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia. Metabolism 2013;62:1065-9
   PubMed Web of Science ®Google Scholar
• Kolovou GD, Anagnostopoulou KK, Pavlidis AN, et al. Postprandial lipaemia in menopausal women with metabolic syndrome. Maturitas 2006;55:19-26
   PubMed Web of Science ®Google Scholar
• Khoury DE, Hwalla N, Frochot V, et al. Postprandial metabolic and hormonal responses of obese dyslipidemic subjects with metabolic syndrome to test meals, rich in carbohydrate, fat or protein. Atherosclerosis 2010;210:307-13
   PubMed Web of Science ®Google Scholar
• Jackson KG, Walden CM, Murray P, et al. A sequential two meal challenge reveals abnormalities in postprandial TAG but not glucose in men with increasing numbers of metabolic syndrome components. Atherosclerosis 2012;220:237-43
   PubMed Web of Science ®Google Scholar
• Kolovou GD, Anagnostopoulou KK, Pavlidis AN, et al. Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects. Lipids Health Dis 2005;4:21
   PubMedGoogle Scholar
• Tushuizen ME, Pouwels PJ, Bontemps S, et al. Postprandial lipid and apolipoprotein responses following three consecutive meals associate with liver fat content in type 2 diabetes and the metabolic syndrome. Atherosclerosis 2010;211:308-14
   PubMed Web of Science ®Google Scholar
• Ginsberg HN, Illingworth DR. Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus. Am J Cardiol 2001;88:9-15H
   PubMed Web of Science ®Google Scholar
• Rivellese AA, De Natale C, Di Marino L, et al. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. J Clin Endocrinol Metab 2004;89:2153-9
   PubMed Web of Science ®Google Scholar
• Annuzzi G, De Natale C, Iovine C, et al. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 2004;24:2397-402
   PubMed Web of Science ®Google Scholar
• Perez-Martinez P, Delgado-Lista J, Perez-Jimenez F, et al. Update on genetics of postprandial lipemia. Atheroscler Suppl 2010;11:39-43
   PubMed Web of Science ®Google Scholar
• Ryan MF, Grada CO, Morris C, et al. Within-person variation in the postprandial lipemic response of healthy adults. Am J Clin Nutr 2013;97:261-7
   PubMed Web of Science ®Google Scholar
• Delgado-Lista J, Perez-Jimenez F, Ruano J, et al. Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men. J Lipid Res 2010;51:63-73
   PubMed Web of Science ®Google Scholar
• Ostos MA, Lopez-Miranda J, Ordovas JM, et al. Dietary fat clearance is modulated by genetic variation in apolipoprotein A-IV gene locus. J Lipid Res 1998;39:2493-500
   PubMed Web of Science ®Google Scholar
• Fisher RM, Burke H, Nicaud V, et al. Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II. EARS Group. J Lipid Res 1999;40:287-94
   PubMed Web of Science ®Google Scholar
• Ostos MA, Lopez-Miranda J, Marin C, et al. The apolipoprotein A-IV-360His polymorphism determines the dietary fat clearance in normal subjects. Atherosclerosis 2000;153:209-17
   PubMed Web of Science ®Google Scholar
• Mendoza-Barbera E, Julve J, Nilsson SK, et al. Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia. J Lipid Res 2013;54:649-61
   PubMed Web of Science ®Google Scholar
• Szalai C, Keszei M, Duba J, et al. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 2004;173:109-14
   PubMed Web of Science ®Google Scholar
• Noto D, Cefalu AB, Cannizzaro A, et al. Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia. Atherosclerosis 2009;206:193-8
   PubMed Web of Science ®Google Scholar
• Lopez-Miranda J, Cruz G, Gomez P, et al. The influence of lipoprotein lipase gene variation on postprandial lipoprotein metabolism. J Clin Endocrinol Metab 2004;89:4721-8
   PubMed Web of Science ®Google Scholar
• Groenemeijer BE, Hallman MD, Reymer PW, et al. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Circulation 1997;95:2628-35
   PubMed Web of Science ®Google Scholar
• Jemaa R, Fumeron F, Poirier O, et al. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Temoin sur l'Infarctus du Myocarde. J Lipid Res 1995;36:2141-6
   PubMed Web of Science ®Google Scholar
• Anagnostopoulou KK, Kolovou GD, Kostakou PM, et al. Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia. Lipids Health Dis 2009;8:24
   PubMed Web of Science ®Google Scholar
• Jimenez-Gomez Y, Perez-Jimenez F, Marin C, et al. The -250G/A polymorphism in the hepatic lipase gene promoter influences the postprandial lipemic response in healthy men. Nutr Metab Cardiovasc Dis 2008;18:173-81
   PubMed Web of Science ®Google Scholar
• Norata GD, Ballantyne CM, Catapano AL. New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs. Eur Heart J 2013;34:1783-9
   PubMed Web of Science ®Google Scholar
• Inazu A, Nakajima K, Nakano T, et al. Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency. Atherosclerosis 2008;196:953-7
   PubMed Web of Science ®Google Scholar
• Kolovou G, Anagnostopoulou K, Kostakou P, et al. Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and postprandial plasma lipoprotein levels in heterozygotes for familial hypercholesterolemia. Clin Chem Lab Med 2007;45:1190-8
   PubMed Web of Science ®Google Scholar
• Kolovou GD, Anagnostopoulou KK, Mikhailidis DP. The link between human and transgenic animal studies involving postprandial hypertriglyceridemia and CETP gene polymorphisms. Open Cardiovasc Med J 2009;3:48-50
   PubMedGoogle Scholar
• Delgado-Lista J, Perez-Martinez P, Perez-Jimenez F, et al. ABCA1 gene variants regulate postprandial lipid metabolism in healthy men. Arterioscler Thromb Vasc Biol 2010;30:1051-7
   PubMed Web of Science ®Google Scholar
• Nakajima K, Nakano T, Tanaka A. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clin Chim Acta 2006;367:36-47
   PubMed Web of Science ®Google Scholar
• Rana JS, Boekholdt SM, Kastelein JJ, et al. The role of non-HDL cholesterol in risk stratification for coronary artery disease. Curr Atheroscler Rep 2012;14:130-4
   PubMed Web of Science ®Google Scholar
• Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007;14(Suppl 2):E1-40
   PubMed Web of Science ®Google Scholar
• van Diepen JA, Berbee JF, Havekes LM, et al. Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis. Atherosclerosis 2013;228:306-15
   PubMed Web of Science ®Google Scholar
• Norata GD, Grigore L, Raselli S, et al. Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies. Atherosclerosis 2007;193:321-7
   PubMed Web of Science ®Google Scholar
• Wang YI, Schulze J, Raymond N, et al. Endothelial inflammation correlates with subject triglycerides and waist size after a high-fat meal. Am J Physiol Heart Circ Physiol 2011;300:H784-91
   PubMed Web of Science ®Google Scholar
• Gower RM, Wu H, Foster GA, et al. CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol 2011;31:160-6
   PubMed Web of Science ®Google Scholar
• Alipour A, van Oostrom AJ, Izraeljan A, et al. Leukocyte activation by triglyceride-rich lipoproteins. Arterioscler Thromb Vasc Biol 2008;28:792-7
   PubMed Web of Science ®Google Scholar
• Lacroix S, Rosiers CD, Tardif JC, et al. The role of oxidative stress in postprandial endothelial dysfunction. Nutr Res Rev 2012;25:288-301
   PubMed Web of Science ®Google Scholar
• van Oostrom AJ, Sijmonsma TP, Verseyden C, et al. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res 2003;44:576-83
   PubMed Web of Science ®Google Scholar
• Halkes CJ, van Dijk H, de Jaegere PP, et al. Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin. Arterioscler Thromb Vasc Biol 2001;21:1526-30
   PubMed Web of Science ®Google Scholar
• Meijssen S, van Dijk H, Verseyden C, et al. Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2002;22:811-16
   PubMed Web of Science ®Google Scholar
• Norata GD, Pirillo A, Callegari E, et al. Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL. Cardiovasc Res 2003;59:169-80
   PubMed Web of Science ®Google Scholar
• Norata GD, Grigore L, Raselli S, et al. Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: molecular mechanisms and gene expression studies. J Mol Cell Cardiol 2006;40:484-94
   PubMed Web of Science ®Google Scholar
• Norata GD, Catapano AL. Triglyceride-rich lipoproteins from normotrygliceridemic subjects and hyperlipidemic patients differently affect endothelial cell activation and gene expression patterns. Circ Res 2007;100:e81
   PubMed Web of Science ®Google Scholar
• Norata GD, Raselli S, Grigore L, et al. Small dense LDL and VLDL predict common carotid artery IMT and elicit an inflammatory response in peripheral blood mononuclear and endothelial cells. Atherosclerosis 2009;206:556-62
   PubMed Web of Science ®Google Scholar
• Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol 1997;79:350-4
   PubMed Web of Science ®Google Scholar
• Lundman P, Eriksson M, Schenck-Gustafsson K, et al. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation 1997;96:3266-8
   PubMed Web of Science ®Google Scholar
• Marchesi S, Lupattelli G, Schillaci G, et al. Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men. Atherosclerosis 2000;153:397-402
   PubMed Web of Science ®Google Scholar
• Maggi FM, Raselli S, Grigore L, et al. Lipoprotein remnants and endothelial dysfunction in the postprandial phase. J Clin Endocrinol Metab 2004;89:2946-50
   PubMed Web of Science ®Google Scholar
• Karpe F, Boquist S, Tang R, et al. Remnant lipoproteins are related to intima–media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. J Lipid Res 2001;42:17-21
   PubMed Web of Science ®Google Scholar
• Karpe F, de Faire U, Mercuri M, et al. Magnitude of alimentary lipemia is related to intima–media thickness of the common carotid artery in middle-aged men. Atherosclerosis 1998;141:307-14
   PubMed Web of Science ®Google Scholar
• Boquist S, Ruotolo G, Tang R, et al. Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima–media thickness in healthy, middle-aged men. Circulation 1999;100:723-8
   PubMed Web of Science ®Google Scholar
• Ryu JE, Howard G, Craven TE, et al. Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke 1992;23:823-8
   PubMed Web of Science ®Google Scholar
• Teno S, Uto Y, Nagashima H, et al. Association of postprandial hypertriglyceridemia and carotid intima–media thickness in patients with type 2 diabetes. Diabetes Care 2000;23:1401-6
   PubMed Web of Science ®Google Scholar
• Mori Y, Itoh Y, Komiya H, et al. Association between postprandial remnant-like particle triglyceride (RLP-TG) levels and carotid intima–media thickness (IMT) in Japanese patients with type 2 diabetes: assessment by meal tolerance tests (MTT). Endocrine 2005;28:157-63
   PubMed Web of Science ®Google Scholar
• Ahmad J, Hameed B, Das G, et al. Postprandial hypertriglyceridemia and carotid intima–media thickness in north Indian type 2 diabetic subjects. Diabetes Res Clin Pract 2005;69:142-50
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG, Benn M, Schnohr P, et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007;298:299-308
   PubMed Web of Science ®Google Scholar
• Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007;298:309-16
   PubMed Web of Science ®Google Scholar
• Mora S, Rifai N, Buring JE, et al. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2008;118:993-1001
   PubMed Web of Science ®Google Scholar
• Langsted A, Freiberg JJ, Tybjaerg-Hansen A, et al. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up. J Intern Med 2011;270:65-75
   PubMed Web of Science ®Google Scholar
• Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, et al. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 2008;300:2142-52
   PubMed Web of Science ®Google Scholar
• Lekhal S, Borvik T, Nordoy A, et al. Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction. Lipids 2008;43:507-15
   PubMed Web of Science ®Google Scholar
• Uiterwaal CS, Grobbee DE, Witteman JC, et al. Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med 1994;121:576-83
   PubMed Web of Science ®Google Scholar
• Lekhal S, Borvik T, Nordoy A, et al. Decreased lipoprotein lipase activity and increased postprandial concentrations of triglyceride-rich lipoproteins in offspring of elderly survivors of myocardial infarction. Nutr Metab Cardiovasc Dis 2008;18:700-6
   PubMed Web of Science ®Google Scholar
• Carstensen M, Thomsen C, Gotzsche O, et al. Differential postprandial lipoprotein responses in type 2 diabetic men with and without clinical evidence of a former myocardial infarction. Rev Diabet Stud 2004;1:175-84
   PubMedGoogle Scholar
• Tibolla G, Norata GD, Artali R, et al. Proprotein convertase subtilisin/kexin type 9 (PCSK9): from structure-function relation to therapeutic inhibition. Nutr Metab Cardiovasc Dis 2011;21:835-43
   PubMed Web of Science ®Google Scholar
• Hovingh GK, Davidson MH, Kastelein JJ, et al. Diagnosis and treatment of familial hypercholesterolaemia. Eur Heart J 2013;34:962-71
   PubMed Web of Science ®Google Scholar
• Cabezas MC, de Bruin TW, Westerveld HE, et al. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia. J Intern Med 1998;244:299-307
   PubMed Web of Science ®Google Scholar
• Mamo JC, Smith D, Yu KC, et al. Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolaemia. Eur J Clin Invest 1998;28:379-84
   PubMed Web of Science ®Google Scholar
• Cabezas MC, de Bruin TW, Jansen H, et al. Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arterioscler Thromb 1993;13:804-14
   PubMed Web of Science ®Google Scholar
• Smith BW, Adams LA. Non-alcoholic fatty liver disease. Crit Rev Clin Lab Sci 2011;48:97-113
   PubMed Web of Science ®Google Scholar
• Musso G, Gambino R, Durazzo M, et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005;42:1175-83
   PubMed Web of Science ®Google Scholar
• Cassader M, Gambino R, Musso G, et al. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients. Lipids 2001;36:1117-24
   PubMed Web of Science ®Google Scholar
• Musso G, Cassader M, De Michieli F, et al. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism. Hepatology 2012;56:933-42
   PubMed Web of Science ®Google Scholar
• Tinker LF, Parks EJ, Behr SR, et al. (n-3) fatty acid supplementation in moderately hypertriglyceridemic adults changes postprandial lipid and apolipoprotein B responses to a standardized test meal. J Nutr 1999;129:1126-34
   PubMed Web of Science ®Google Scholar
• Slivkoff-Clark KM, James AP, Mamo JC. The chronic effects of fish oil with exercise on postprandial lipaemia and chylomicron homeostasis in insulin resistant viscerally obese men. Nutr Metab (Lond) 2012;9:9
   PubMed Web of Science ®Google Scholar
• Ooi EM, Lichtenstein AH, Millar JS, et al. Effects of therapeutic lifestyle change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects. J Lipid Res 2012;53:1958-67
   PubMed Web of Science ®Google Scholar
• Karjalainen JJ, Kiviniemi AM, Hautala AJ, et al. Effects of exercise prescription on daily physical activity and maximal exercise capacity in coronary artery disease patients with and without type 2 diabetes. Clin Physiol Funct Imaging 2012;32:445-54
   PubMed Web of Science ®Google Scholar
• Park Y, Harris WS. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res 2003;44:455-63
   PubMed Web of Science ®Google Scholar
• King JM, Crouse JR, Terry JG, et al. Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia. Am J Med 1994;97:323-31
   PubMed Web of Science ®Google Scholar
• O'Keefe JH Jr, Harris WS, Nelson J, et al. Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia. Am J Cardiol 1995;76:480-4
   PubMed Web of Science ®Google Scholar
• Carlson LA, Oro L, Ostman J. Effect of a single dose of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia. Acta Med Scand 1968;183:457-65
   PubMedGoogle Scholar
• Plaisance EP, Mestek ML, Mahurin AJ, et al. Postprandial triglyceride responses to aerobic exercise and extended-release niacin. Am J Clin Nutr 2008;88:30-7
   PubMed Web of Science ®Google Scholar
• Usman MH, Qamar A, Gadi R, et al. Extended-release niacin acutely suppresses postprandial triglyceridemia. Am J Med 2012;125:1026-35
   PubMed Web of Science ®Google Scholar
• HPS2-THRIVE Collaborative Group. HPS2-THRIVE randomized placebo-controlled trial in 25,673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment. Eur Heart J 2013;34:1279-91
   PubMed Web of Science ®Google Scholar
• Teo KK, Goldstein LB, Chaitman BR, et al. Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial. Stroke 2013;44:2688-93
   PubMed Web of Science ®Google Scholar
• Kolovou GD, Kostakou PM, Anagnostopoulou KK, et al. Therapeutic effects of fibrates in postprandial lipemia. Am J Cardiovasc Drugs 2008;8:243-55
   PubMed Web of Science ®Google Scholar
• Irvin MR, Kabagambe EK, Tiwari HK, et al. Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study. Circ Cardiovasc Genet 2010;3:462-7
   PubMedGoogle Scholar
• Kolovou GD, Anagnostopoulou KK, Salpea KD, et al. The effect of statins on postprandial lipemia. Curr Drug Targets 2007;8:551-60
   PubMed Web of Science ®Google Scholar
• Ceriello A, Assaloni R, Da Ros R, et al. Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 2005;111:2518-24
   PubMed Web of Science ®Google Scholar
• Ceriello A, Taboga C, Tonutti L, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002;106:1211-18
   PubMed Web of Science ®Google Scholar
• Nagashima H, Endo M. Pitavastatin prevents postprandial endothelial dysfunction via reduction of the serum triglyceride level in obese male subjects. Heart Vessels 2011;26:428-34
   PubMed Web of Science ®Google Scholar
• Chan DC, Watts GF, Barrett PH, et al. Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test. J Lipid Res 2002;43:706-12
   PubMed Web of Science ®Google Scholar
• Hogue JC, Lamarche B, Deshaies Y, et al. Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia. Metabolism 2008;57:246-54
   PubMed Web of Science ®Google Scholar
• Bozzetto L, Annuzzi G, Corte GD, et al. Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes. Atherosclerosis 2011;217:142-8
   PubMed Web of Science ®Google Scholar
• Hajer GR, Dallinga-Thie GM, van Vark-van der Zee LC, et al. The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients. Atherosclerosis 2009;202:216-24
   PubMed Web of Science ®Google Scholar
• Masuda D, Nakagawa-Toyama Y, Nakatani K, et al. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia. Eur J Clin Invest 2009;39:689-98
   PubMed Web of Science ®Google Scholar
• Tremblay AJ, Lamarche B, Hogue JC, et al. Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia. J Lipid Res 2009;50:1463-71
   PubMed Web of Science ®Google Scholar
• Kikuchi K, Nezu U, Inazumi K, et al. Double-blind randomized clinical trial of the effects of ezetimibe on postprandial hyperlipidaemia and hyperglycaemia. J Atheroscler Thromb 2012;19:1093-101
   PubMed Web of Science ®Google Scholar
• Chan DC, Watts GF, Gan SK, et al. Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet. Diabetes Care 2010;33:1134-9
   PubMed Web of Science ®Google Scholar
• Cuchel M, Meagher EA, du Toit Theron H, et al. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study. Lancet 2013;381:40-6
   PubMed Web of Science ®Google Scholar
• Gaudet D, de Wal J, Tremblay K, et al. Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency. Atheroscler Suppl 2010;11:55-60
   PubMed Web of Science ®Google Scholar
• Carpentier AC, Frisch F, Labbe SM, et al. Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients. J Clin Endocrinol Metab 2012;97:1635-44
   PubMed Web of Science ®Google Scholar
• Norata GD, Tibolla G, Catapano AL. Gene silencing approaches for the management of dyslipidaemia. Trends Pharmacol Sci 2013;34:198-205
   PubMed Web of Science ®Google Scholar
• Thomas GS, Cromwell WC, Ali S, et al. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2013;62:2178-84
   PubMed Web of Science ®Google Scholar
• Furtado JD, Wedel MK, Sacks FM. Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins. J Lipid Res 2012;53:784-91
   PubMed Web of Science ®Google Scholar
• Meyers C, Gaudet D, Tremblay K, et al. The DGAT1 inhibitor LCQ908 decreases triglyceride levels in patients with the familial chylomicronemia syndrome. J Clin Lipidol 2012;6:266-7
   Google Scholar
• Norata GD, Garlaschelli K, Grigore L, et al. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population. Nutr Metab Cardiovasc Dis 2009;19:129-34
   PubMed Web of Science ®Google Scholar
• Norata GD, Baragetti I, Raselli S, et al. Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status. Nutr Metab Cardiovasc Dis 2010;20:56-63
   PubMed Web of Science ®Google Scholar
• Kolovou GD, Mikhailidis DP, Nordestgaard BG, et al. Definition of postprandial lipaemia. Curr Vasc Pharmacol 2011;9:292-301
   PubMed Web of Science ®Google Scholar
• Mihas C, Kolovou GD, Mikhailidis DP, et al. Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis. Curr Vasc Pharmacol 2011;9:271-80
   PubMed Web of Science ®Google Scholar